EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Addressing the in vivo delivery of nucleic-acid nanostructure therapeutics

Shana Alexander, Mohammadamir G Moghadam, Meghan Rothenbroker, Leo Y T Chou

Advanced Drug Delivery Reviews · 2023-08 · 199 · 114898

DOI: 10.1016/j.addr.2023.114898 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-08. Verfasst von Shana Alexander und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada. Hauptthemen laut MEDLINE: Nucleic Acids, Nanostructures. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 353 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA and RNA nanostructures are being investigated as therapeutics, vaccines, and drug delivery systems. These nanostructures can be functionalized with guests ranging from small molecules to proteins with precise spatial and stoichiometric control. This has enabled new strategies to manipulate drug activity and to engineer devices with novel therapeutic functionalities. Although existing studies have offered encouraging in vitro or pre-clinical proof-of-concepts, establishing mechanisms of in vivo delivery is the new frontier for nucleic-acid nanotechnologies. In this review, we first provide a summary of existing literature on the in vivo uses of DNA and RNA nanostructures. Based on their application areas, we discuss current models of nanoparticle delivery, and thereby highlight knowledge gaps on the in vivo interactions of nucleic-acid nanostructures. Finally, we describe techniques and strategies for investigating and engineering these interactions. Together, we propose a framework to establish in vivo design principles and advance the in vivo translation of nucleic-acid nanotechnologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nucleic AcidsNanostructuresHumansDNANanotechnologyRNA

Stichwörter der Autor:innen

DNA nanostructuresDelivery systemIn vivo barriersNano-bio interfaceNanoparticlesRNA nanostructures

Substanzen

Nucleic AcidsDNARNA

Autor:innen und Institutionen

  • Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada.
  • Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada. Electronic address: leo.chou@utoronto.ca.

Zitieren

APA

Alexander, S., Moghadam, M. G., Rothenbroker, M., & Y T Chou, L. (2023). Addressing the in vivo delivery of nucleic-acid nanostructure therapeutics. Advanced Drug Delivery Reviews, 199, 114898. https://doi.org/10.1016/j.addr.2023.114898

Vancouver

Alexander S, Moghadam MG, Rothenbroker M, Y T Chou L. Addressing the in vivo delivery of nucleic-acid nanostructure therapeutics. Advanced Drug Delivery Reviews. 2023;199:114898. doi:10.1016/j.addr.2023.114898

BibTeX
@article{Alexander2023,
  author = {Alexander, Shana and Moghadam, Mohammadamir G and Rothenbroker, Meghan and Y T Chou, Leo},
  title = {Addressing the in vivo delivery of nucleic-acid nanostructure therapeutics},
  journal = {Advanced Drug Delivery Reviews},
  year = {2023},
  volume = {199},
  pages = {114898},
  doi = {10.1016/j.addr.2023.114898}
}
Kostenlos starten →